Cargando…
A six-long noncoding RNA model predicts prognosis in lung adenocarcinoma
BACKGROUND: The incidence and mortality of lung cancer rank first among various malignant tumors. The lack of clear molecular classification and effective individualized treatment greatly limits the treatment benefits of patients. Long non-coding RNAs (lncRNAs) have been demonstrated widely involve...
Autores principales: | Bai, Yuquan, Deng, Senyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799207/ https://www.ncbi.nlm.nih.gov/pubmed/35117351 http://dx.doi.org/10.21037/tcr-20-2436 |
Ejemplares similares
-
A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
por: Bai, Yuquan, et al.
Publicado: (2022) -
Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021) -
A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma
por: Liao, Meijian, et al.
Publicado: (2018) -
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
por: Zhang, Chuanfen, et al.
Publicado: (2022) -
Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
por: Yang, Longjun, et al.
Publicado: (2022)